Amarin | AMRN - Umsatzerlöse





Der Umsatz Veränderung Datum
AbbVie USD 16.99B 1.99B 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Amarin USD 49.22M 451K 2025-12
AstraZeneca USD 15.38B 90M 2026-06
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
DBV Technologies USD 645K 2.13M 2025-12
GlaxoSmithKline GBP 8.41B 781M 2026-06
Halozyme Therapeutics USD 481M 104M 2026-06
Heron Therapeutics USD 40.59M 2.38M 2025-12
Ionis Pharmaceuticals USD 268M 22M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 959M 148M 2026-06
Novartis USD 14.41B 1.3B 2026-06